Solana (SOL) Plunges 20%—Key Support Levels Now in Focus
Solana started a fresh decline from the $180 zone. SOL price is down over 20% and might struggle to recover above the $150 resistance.
- SOL price started a fresh decline below the $162 and $150 levels against the US Dollar.
- The price is now trading below $150 and the 100-hourly simple moving average.
- There was a break below a connecting bullish trend line with support at $148 on the hourly chart of the SOL/USD pair (data source from Kraken).
- The pair could start a fresh increase if the bulls clear the $150 zone.
Solana Price Dips Heavily
Solana price struggled to clear the $180 resistance and started a fresh decline, like Bitcoin and Ethereum . SOL declined below the $165 and $155 support levels.
It even dived below the $150 level. There was a break below a connecting bullish trend line with support at $148 on the hourly chart of the SOL/USD pair. The recent low was formed at $132 and the price is now consolidating losses with a bearish angle.
Solana is now trading below $140 and the 100-hourly simple moving average. On the upside, the price is facing resistance near the $140 level. The next major resistance is near the $144 level or the 23.6% Fib retracement level of the downward move from the $180 swing high to the $132 swing low.
Source: SOLUSD on TradingView.comThe main resistance could be $156 and the 50% Fib retracement level of the downward move from the $180 swing high to the $132 swing low. A successful close above the $156 resistance zone could set the pace for another steady increase. The next key resistance is $165. Any more gains might send the price toward the $180 level.
More Losses in SOL?
If SOL fails to rise above the $148 resistance, it could start another decline. Initial support on the downside is near the $132 zone. The first major support is near the $125 level.
A break below the $125 level might send the price toward the $120 zone. If there is a close below the $120 support, the price could decline toward the $102 support in the near term.
Technical Indicators
Hourly MACD – The MACD for SOL/USD is gaining pace in the bearish zone.
Hourly Hours RSI (Relative Strength Index) – The RSI for SOL/USD is below the 50 level.
Major Support Levels – $132 and $125.
Major Resistance Levels – $148 and $156.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Banks retreat, bond discounts, and it's hard to borrow money for the AI construction boom
Discounted sales of high-yield bonds have become the new norm—among this year's $55 billion related bonds, the most recent four issuances were all at a discount; major banks such as Société Générale and Mitsubishi are adopting a more cautious approach; Oracle's force majeure event has further prompted lenders to tighten their terms. With $700 billion in capital expenditures from mega-tech companies competing for financing, combined with rising Treasury yields, the cost of funding for some projects is approaching the break-even point. Developers with lower ratings and less experience are being hit first.

Trading congestion! Bank of America warns: "Buy AI, sell consumer" strategies are increasingly difficult to generate excess returns
Active fund holdings have already fully reflected the theme of "consumption shifting to capital expenditure." It is becoming increasingly difficult to generate excess returns by buying beneficiaries of AI capital expenditure and selling white-collar consumption themes.
Replica of the "Semiconductor Moment": The "Bottleneck Trade" in AI Drug Discovery Is Taking Shape—Who Will Be the Next "Shovel Seller"?
Investor Freda Duan pointed out that AI-driven drug development is shaping structural opportunities similar to "bottleneck trades" in the semiconductor industry. The core logic is that AI turns failed experiments into valuable training data, and wet laboratories are transforming from "medicine making" to "data creation." DNA synthesis, protein production, and CROs may become the earliest beneficiaries as the "pick-and-shovel sellers."
